Downstream intracellular effectors of epidermal growth factor receptor as targets for anticancer therapy

Author： Milano Amalia   De Rosa Vincenzo   Iaffaioli Rosario Vincenzo   Caponigro Francesco  

Publisher： Informa Healthcare

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.11, Iss.6, 2007-06, pp. : 771-782

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mutant Epidermal Growth Factor Receptors as Targets for Cancer Therapy

By  

Current Cancer Drug Targets, Vol. 2, Iss. 2, 2002-06 ,pp. : 91-102

Bentham Science Publishers

Access to resources Recommend Favorite

ZD1839: targeting the epidermal growth factor receptor in cancer therapy

By Herbst Roy S  

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 6, 2002-06 ,pp. : 837-849

Informa Healthcare

Access to resources Recommend Favorite

Anti-epidermal growth factor receptor drugs in cancer therapy

By Tortora Giampaolo   Ciardiello Fortunato  

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 6, 2002-06 ,pp. : 755-768

Informa Healthcare

Access to resources Recommend Favorite

The Role of Downstream Signaling Pathways of the Epidermal Growth Factor Receptor for Artesunate's Activity in Cancer Cells

By  

Current Cancer Drug Targets, Vol. 9, Iss. 1, 2009-02 ,pp. : 72-80

Bentham Science Publishers

Access to resources Recommend Favorite

Crosstalk Between Epidermal Growth Factor Receptor- and Insulin-Like Growth Factor-1 Receptor Signaling: Implications for Cancer Therapy

By  

Current Cancer Drug Targets, Vol. 9, Iss. 6, 2009-09 ,pp. : 748-760

Bentham Science Publishers

Access to resources Recommend Favorite